Lelia Delamarre

Company: Genentech

Job title: Director, Cancer Immunology Research & Distinguished Scientist

Seminars:

Discussing the Latest Clinical Data for mRNA Cancer Vaccines to Help Advance Your mRNA Candidate 9:30 am

What is the latest clinical data on the advancement in mRNA cancer vaccines? How to move your mRNA cancer vaccine into commercialization What are the possible breakthroughs or innovations we may see in the next year for mRNA cancer vaccines?Read more

day: Conference Day One

Roundtable Discussion: Reviewing the Next Generation of RNA Technologies as an Alternative Candidate for Use in Cancer Vaccines 11:30 am

Revealing how sa-RNA is capable of inducing a strong immune response in the body allowing it to be an ideal candidate for use in cancer vaccines Showing how circular-RNA has been found to be more stable and resistant to degradation than other forms of RNA Investigating how si-RNA is capable of silencing specific genes that…Read more

day: Conference Day One